Insider Buying: Neonc Technologies (NASDAQ:NTHI) CEO Purchases $19,972.02 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Thomas Chen bought 5,242 shares of the stock in a transaction dated Monday, September 14th. The shares were acquired at an average cost of $3.81 per share, for a total transaction of $19,972.02. Following the completion of the acquisition, the chief executive officer directly owned 24,503 shares of the company’s stock, valued at approximately $93,356.43. This trade represents a 27.22% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Neonc Technologies Trading Up 14.0%

Shares of NTHI stock opened at $3.41 on Friday. Neonc Technologies Holdings, Inc. has a 1 year low of $2.95 and a 1 year high of $12.99. The stock has a 50 day simple moving average of $3.98 and a 200 day simple moving average of $5.18.

Neonc Technologies (NASDAQ:NTHI) last posted its quarterly earnings data on Monday, August 10th. The company reported ($0.58) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.46).

Analyst Upgrades and Downgrades

NTHI has been the subject of a number of analyst reports. Weiss Ratings downgraded Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday. BTIG Research reiterated a “buy” rating and set a $15.00 price objective on shares of Neonc Technologies in a research note on Tuesday, September 8th. Finally, Wall Street Zen lowered shares of Neonc Technologies from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $16.00.

Hedge Funds Weigh In On Neonc Technologies

Several hedge funds and other institutional investors have recently modified their holdings of NTHI. Global Retirement Partners LLC bought a new position in shares of Neonc Technologies in the 2nd quarter valued at $126,000. BlackRock Inc. bought a new stake in shares of Neonc Technologies during the 2nd quarter worth $815,000. Westmount Partners LLC lifted its position in shares of Neonc Technologies by 355.2% during the 2nd quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after buying an additional 153,858 shares during the last quarter. Finally, Bank of America Corp DE acquired a new stake in Neonc Technologies in the second quarter valued at about $1,017,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.